Abstract:The anti‐psoriasis activity of flavonoids from Sophora flavescens. The herb Sophora flavescens displays anti‐inflammatory activity and can provide a source of antipsoriatic medications. We aimed to evaluate whether S. flavescens extracts and compounds can relieve psoriasiform inflammation. The ability of flavonoids (maackiain, sophoraflavanone G, leachianone A) and alkaloids (matrine, oxymatrine) isolated from S. flavescens to inhibit production of cytokine/chemokines was examined in keratinocytes and macrophages. Physicochemical properties and skin absorption were determined by in silico molecular modeling and the in vitro permeation test (IVPT) to establish the structure‐permeation relationship (SPR). The ethyl acetate extract exhibited higher inhibition of interleukin (IL)‐6, IL‐8, and CXCL1 production in tumor necrosis factor‐α‐stimulated keratinocytes compared to the ethanol and water extracts. The flavonoids demonstrated higher cytokine/chemokine inhibition than alkaloids, with the prenylated flavanones (sophoraflavanone G, leachianone A) led to the highest suppression. Flavonoids exerted anti‐inflammatory effects via the extracellular signal‐regulated kinase, p38, activator protein‐1, and nuclear factor‐κB signaling pathways. In the IVPT, prenylation of the flavanone skeleton significantly promoted skin absorption from 0.01 to 0.22 nmol/mg (sophoraflavanone G vs. eriodictyol). Further methoxylation of a prenylated flavanone (leachianone A) elevated skin absorption to 2.65 nmol/mg. Topical leachianone A reduced the epidermal thickness in IMQ‐treated mice by 47%, and inhibited cutaneous scaling and cytokine/chemokine overexpression at comparable levels to a commercial betamethasone product. Thus, prenylation and methoxylation of S. flavescens flavanones may enable the design of novel antipsoriatic agents.

Flavonoids from the Aerial Parts of Sophora tonkinensis and Their Potential Anti‐inflammatory Activities

Non-alkaloid components with inhibitory activity against LPS induced NO production in RAW 264.7 cells isolated from the roots of Sophora flavescens

Anti-inflammation of Flavonoid Compounds from Dalbergia Odorifera T.Chen in Lipopolysaccharide Stimulated RAW264.7 Macrophages

Sophoranone A and B: two new cytotoxic prenylated metabolites and their analogs from the root bark of Sophora flavescens

Two New Isoprenoid Flavonoids from Sophora flavescens with Antioxidant and Cytotoxic Activities

Isoprenylated flavonoids from the roots of Sophora tonkinensis

Nmr Spectral Assignments of Isoprenylated Flavanones from Sophora Tonkinensis

Estrogenic Prenylated Flavonoids in Sophora flavescens

Three new flavonoids from the roots of Sophora tonkinensis

[Chemical Constituents of Flavonoids from Rhizome of Sophora Tonkinensis].

Prenylated Flavonoids in Sophora flavescens: A Systematic Review of Their Phytochemistry and Pharmacology

Quinolizidine alkaloids from Sophora alopecuroides with anti-inflammatory and anti-tumor properties

Anti-Inflammatory and antiproliferative activities of trifolirhizin, a flavonoid from Sophora flavescens roots.

The anti‐inflammatory activity of flavonoids and alkaloids from Sophora flavescens alleviates psoriasiform lesions: Prenylation and methoxylation beneficially enhance bioactivity and skin targeting

New phenylpropanoid derivatives from the fruits of Xanthium sibiricum and their anti-inflammatory activity.

Three Cyclized Isoprenylated Flavonoids from the Roots and Rhizomes of Sophora Tonkinensis

A new flavonoid from Sophora flavescens Ait.

Five Novel Pterocarpan Derivatives from Sophora flavescens

Flavonoids with anti-inflammatory activities from Daphne giraldii

Prenylated Dihydroflavonol from Sophora flavescens Regulate the Polarization and Phagocytosis of Macrophages In Vitro

Five matrine-type alkaloids from Sophora tonkinensis